Drug Sponsors Urge FDA to Think Bigger about Master Protocols

Drug Industry Daily
A A
Leading drugmakers are urging the FDA to think bigger about its master protocol guidelines for clinical trials and expand beyond cancer trials.

To View This Article:

Login

Subscribe To Drug Industry Daily